Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

MDT ABT SYK STJ Corporate Bonds Data Storage Small Growth 
Benchmark  United States  NYSE  10,937   50.536 Index Moved Down -0.46%  

Processing. Please wait...

Stryker Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.




Money Received


Discounts and Returns

9.14 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare Stryker to competition

Stryker Revenue Assessment

Based on latest financial disclosure Stryker Corporation reported 9.14 B of revenue. This is 77.03% higher than that of the Healthcare sector, and 487.23% higher than that of Medical Appliances and Equipment industry, The Revenue for all stocks is 46.11% higher than the company.

Filter other Stocks by Revenue

Specify Market Cap
Select Revenue Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
Found 10 equities


MDT NYQMedtronic Inc
16.89 B
ABT NYQAbbott Laboratories
21.71 B
SYK NYQStryker Corporation
9.14 B
STJ NYQSt Jude Medical Inc
5.53 B
ZMH NYQZimmer Holdings Inc
4.65 B
BSX NYQBoston Scientific Corporation
7.16 B
SNN NYQSmith Nephew plc
4.35 B
ISRG NMSIntuitive Surgical Inc
2.12 B
EW NYQEdwards Lifesciences Corp
2.07 B
VAR NYQVarian Medical Systems Inc
2.99 B
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Stryker Corporation is rated fourth in revenue category among related companies. Market size based on revenue of Medical Appliances and Equipment industry is at this time estimated at about 85.75 Billion. Stryker retains roughly 9.14 Billion in revenue claiming about 11% of all equities under Medical Appliances and Equipment industry.

Fix Your Portfolios with Stryker

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Stryker Corporation to your portfolio

Stryker Corporation Profile

Stryker Corporation
USA Stock
Currency: USD - US Dollar
Traded on New York Stock Exchange

Other Stryker Fundamentals

Return On Equity8.81 %
Return On Asset4.77 %
Profit Margin8.45 %
Operating Margin12.64 %
Current Valuation30.85 B
Shares Outstanding379.09 M
Shares Owned by Insiders19.01 %
Shares Owned by Institutions70.00 %
Number of Shares Shorted4.34 M
Price to Earning42.35 times
Price to Book3.53 times
Price to Sales3.50 times
Revenue9.14 B
Gross Profit6.04 B
Net Income772 M
Cash and Equivalents4.05 B
Cash per Share10.68 times
Total Debt3.06 B
Debt to Equity0.34 times
Current Ratio2.37 times
Book Value Per Share23.91 times
Cash Flow from Operations1.86 B
Short Ratio3.30 times
One Year High86.93
One Year Low63.71
Earnings Per Share2.02 times
Price to Earnings To Growth1.96 times
Number of Employees25 K
Market Capitalization32.41 B
Total Asset16.16 B
Retained Earnings7.57 B
Working Capital4.89 B
Current Asset8.45 B
Current Liabilities3.56 B
Z Score6.0
Probability Of Bankruptcy10.01 %

Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities